WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker as President Trump signed the Opioid Crisis Response Act of 2018 that would address the opioid crisis:
Top News
Statement | October 24, 2018
Blog Post | October 11, 2018
Last week, an article by Barbara Bridgman Perkins, PhD, was published in the Washington Post admonishing the relationships between industry and health care providers to advance radiotherapy treatment. Here is what I submitted in response.
Press Release | October 8, 2018
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Matthew Wetzel, vice president and assistant general counsel, regarding this week’s filing of an amicus curiae brief with the Utah Supreme Court in the case of Burningham v. Wright Medical:
Events
November
15
November 15, 2018 | Virtual
Many companies today are aware of the broader paperless evolution. For medical device manufacturers and other highly regulated companies, though, the risks and costs of transitioning fully from paper... Read More
November
28
November 28, 2018 | 45 Independence Ave SW Washington, DC 20515
Join us for an interactive experience exploring the medical technology industry's innovations in diabetes prevention, management and treatment.
Heavy hors d'oeuvres will be served.
Contact cpaul@... Read More
December
04
December 4, 2018 to December 5, 2018
| Washington, DC Register before November 2nd and save $200 with early bird pricing!
During this workshop you'll establish a clear understanding how the regulatory affairs function is pivotal to every... Read More
December
11
December 11, 2018 to December 12, 2018
| Washington, DC Register before November 9th and save $200 with early bird pricing!
VIEW THE AGENDA HERE
The medtech industry is one of the key industries in China, where the market demands for high value medical... Read More
Featured Video
The medical technology industry is committed to safety, effectiveness and quality for all devices. Companies employ scientists, physicians, engineers, quality experts and other professionals to research and examine every aspect of a medical device to ensure that it performs as intended.
Industry News
RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...
Twitter Feed
November 14, 2018 - 11:01am
AdvaMed COO @ChrisMedTech celebrates @UK_ABHI’s 30th anniversary. Read his newest blog post. https://t.co/4KjMq1sinm
November 13, 2018 - 2:01pm
Going before an advisory committee can be make-or-break for a company and industry reps can play a critical role.… https://t.co/kZcdDq3kqM